Therefore, further analyses using rodent models of chronic PD (e.g., the MPTP/probenecid chronic model) may clarify the effects of chronic administration of selegiline on NMS-like behavior in PD and on the expression levels of other proteins associated with synaptic plasticity, such as brain derived neurotrophic factors. This evidence concerns the gene BDNF and Parkinson disease.